http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1166861-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6506cf133be42545d51d1490056f6af
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-113
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
filingDate 1966-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1282100eebced16b761748c0116468e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e35d8ef597a5ff8d88790e2c5721c364
publicationDate 1969-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1166861-A
titleOfInvention New Diphenylamine Derivatives and Compositions containing them
abstract 1,166,861. Anti-inflammnatory &c. composilions. ASPRO-NICHOLAS Ltd. 9 Jan., !967 [15 Jan., 1966], No. 2004/66. Heading A5B. [Also in Division C2] Pharmaceutical compositions having antiinflammatory and analgesic action comprise compounds of the formula: wherein R. represents 1,3,4-oxadiazol-2-one, l,2,4-triazol-3-one or COOR 2 , wherein R 2 , represents H or a group hydrolysable to H. and salts thereof, together with a pharmaceutically acceptable diluent or carrier in forms suitable for oral, parenteral or rectal administration. The compositions may also contain one or more other pharmacologically active ingredients, e.g. acetylsalicylic acid, aspirin anhydride, 1:3-benzoxazine-2:4-dione, 3-methylsalicylic acid. an aluminium aspirin compound (e.g. aloxiprin) caffeine, codeine phosphate, phenazone, paracetamol, amidopyrine, phenylbutazone, salicylamides, C 1-4 alkoxy-nuclear-substituted derivatives of salicylamide or toluamide, and alkoxy and alkoxyalkyl nuclearsubstituted derivatives of benzamide.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015120703-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10233198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0401857-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5462952-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0401857-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9371284-B2
priorityDate 1966-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408295384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18428992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425470349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448487131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450772054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421298036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321303
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419833942

Total number of triples: 47.